Objectives: To assess the efficacy of valsartan in a different ethnic population than that
studied in international trials. Also to compare the adverse experiences reported in this trial …

An open label, optional titration trial to evaluate the efficacy, tolerability and safety of
Valsartan 80mg od/Valsartan 160mg od in patients with mild to moderate hypertension …

Objective: To compare the therapeutic efficacy and tolerability of the angiotensin II receptor
blocker valsartan given 160 mg od with that of the ACE-inhibitor lisinopril given 20 mg od …

Objective: To compare the efficacy, safety and tolerability of valsartan to an angiotensin-
converting enzyme (ACE) inhibitor, lisinopril, and placebo in patients with mild-to-moderate …

Objective. To evaluate the efficacy and safety of valsartan in Taiwanese patients with
essential hypertension. Methods. This 12-week multi-center, open-label, observational, post …

A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …

Objective This study was designed mainly to establish the rates of response to valsartan 80
mg once daily (qd) and to valsartan 160 mg qd given to non-responders to 80 mg qd, as well …

Objective: To study the efficacy and tolerability of a range of valsartan doses in patients with
mild-to-moderate hypertension. Design: 122 adult out-patients were randomised in equal …

Objective: To compare the efficacy of valsartan in systolic (SBP) and diastolic blood pressure
(DBP) reduction with other angiotensin II receptor blockers (ARBs) in essential hypertension …

We reviewed the Chinese and English literature for the efficacy and safety data of valsartan
monotherapy or combination therapy in Chinese hypertensive patients. According to the …